EPISODE · Apr 23, 2026 · 1 MIN
Dexcom Thrives Amid Weight Loss Drug Race
from The Daily News Now! Business
Dexcom, a continuous glucose monitor specialist, is poised for growth amidst the weight loss boom, despite risks associated with competitors like Eli Lilly and Novo Nordisk. Contrary to initial concerns, GLP-one drugs have actually increased CGM usage. Dexcoms strategic positioning, with over-the-counter options and a network of compatible devices, sets it apart from pharma giants, ensuring steady gains as it taps into the vast, underserved CGM market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ac11c73d5757ffbc
NOW PLAYING
Dexcom Thrives Amid Weight Loss Drug Race
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m